Help raise the $505,000 needed for the OPT-Pembro clinical trial, and change treatment for women like Natalie.

Natalie was diagnosed with breast cancer while raising a young family.

Her intense treatment took a devastating toll – physically, emotionally, and on her future.

Now,  you can help fund a new clinical trial that can identify whether some women like Natalie may safely avoid unnecessary treatment.

“OPT-Pembro could help reduce the amount of treatment and associated side effects – all without compromising patient outcomes.

It would mean some women with triple negative breast cancer could get back to their lives and families sooner.”

– Dr Julia Dixon-Douglas, OPT-Pembro clinical trial Study Co-Chair.

Your gift today could help women like Natalie survive aggressive breast cancer with less treatment and return to their loved ones sooner.

Right now, treatment options for women diagnosed with triple negative breast cancer are limited and can come with serious side effects.

Natalie was 42 when she was diagnosed. She remembers that she and her husband, Ross, left the doctor’s office in tears. They had three primary-school-aged children waiting for them at home.

“I can’t die,” Natalie remembers thinking. “I have to stay alive for my children.”

Natalie knew that the treatment ahead of her would be hard. This was her second breast cancer diagnosis. But this time, she had triple negative breast cancer which is aggressive and hard to treat.

The OPT-Pembro clinical trial could help women with breast cancer like Natalie’s have less treatment and still get the same outcome.

Will you please donate here now and get this breast cancer research going?

OPT-Pembro has great potential to help stop breast cancer cutting lives short – but only if it’s funded.

Don’t delay. Please make your tax-deductible donation here now, and fund the OPT-Pembro breast cancer clinical trial.